We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M Turnover 25%
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+32.96%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.4M
AUM Growth
+$704K
Cap. Flow
+$1.96M
Cap. Flow %
2.27%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–
Avg Time Held
2 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2 years

Top Buys

Rank Stock Value
1
SPRB icon
Spruce Biosciences
SPRB
+$1.95M
2
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$12.2K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MIRM icon
1
Mirum Pharmaceuticals
MIRM
$5.2B
$38.9M 45.05%
1,621,118
– –
2020 Q4
9 quarters
ALLK icon
2
DELISTED
Allakos
ALLK
$21.8M 25.17%
4,887,932
– –
2020 Q4
9 quarters
OKUR icon
3
OnKure Therapeutics
OKUR
$85M
$14.4M 16.67%
240,922
– –
2021 Q2
7 quarters
SPRB icon
4
Spruce Biosciences
SPRB
$114M
$6.49M 7.51%
39,150
+10,506
+37% +$1.95M
2020 Q4
9 quarters
XLO icon
5
Xilio Therapeutics
XLO
$56.3M
$4.57M 5.29%
102,960
– –
2021 Q4
5 quarters
VAPO
6
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$278K 0.32%
52,882
+1,312
+3% +$12.2K
2020 Q4
9 quarters

Similar funds

JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return

RiverVest Venture Management's Q1 2023 Portfolio in Review

As of Q1 2023, RiverVest Venture Management held 6 positions worth $86.4M, up 0.82% from $85.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management added most to Spruce Biosciences in Q1 2023, an estimated $1.95M increase.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $86.4M portfolio in Q1 2023.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q1 2023.
  • RiverVest Venture Management's portfolio value rose 0.82% quarter-over-quarter to $86.4M.

Based on RiverVest Venture Management's 13F filing for Q1 2023, filed 27 Apr 2023.